Expectant management with selective delayed intervention for favorable-risk prostate cancer

被引：0
|
作者：
Klotz, L [1 ]
机构：
[1] Univ Toronto, Sunnybrook & Womens Coll, Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada
来源：
PROSTATE AND RENAL CANCER, BENIGN PROSTATIC HYPERPLASIA, ERECTILE DYSFUNCTION AND BASIC RESEARCH: AND UPDATE | 2003年
关键词：
D O I：
暂无
中图分类号：
R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
摘要：
引用
收藏
页码：274 / 279
页数：6
相关论文
共 50 条
  • [41] Localized prostate cancer: early intervention or expectant therapy?
    Griffiths, TRL
    Neal, DE
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1997, 90 (12) : 665 - 669
  • [42] Active surveillance with selective delayed intervention using PSA doubling time for good risk prostate cancer
    Klotz, L
    EUROPEAN UROLOGY, 2005, 47 (01) : 16 - 21
  • [43] Risk of missing advanced stage or high grade tumors during active surveillance (AS) even in favorable-risk prostate cancer (PC)
    Kim, Jeri
    Ward, John Francis
    Pettaway, Curtis A.
    Wang, Xuemei
    Kuban, Deborah A.
    Frank, Steven J.
    Lee, Andrew
    Pisters, Louis L.
    Matin, Surena F.
    Shah, Jay Bakul
    Karam, Jose A.
    Chapin, Brian Francis
    Papadopoulos, John N.
    Achim, Mary F.
    Hoffman, Karen Elizabeth
    Pugh, Thomas J.
    Choi, Seungtaek
    Logothetis, Christopher
    Troncoso, Patricia
    Davis, John W.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [44] Predictors of delayed therapy after expectant management for localized prostate cancer in the era of prostate-specific antigen
    Panagiotou, I
    Beer, TM
    Hsieh, YC
    Mori, M
    Peters, L
    Klein, T
    Garzotto, M
    ONCOLOGY, 2004, 67 (3-4) : 194 - 202
  • [45] Long-term outcomes of magnetic resonance image-guided partial prostate brachytherapy for favorable-risk prostate cancer.
    King, Martin T.
    Nguyen, Paul L.
    Boldbaatar, Ninjiin
    Tempany, Clare Mary
    Cormack, Robert A.
    Beard, Clair
    Hurwitz, Mark
    Suh, Warren
    D'Amico, Anthony Victor
    Orio, Peter F.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [46] UTILITY OF PTEN/ERG STATUS IN A CONTEMPORARY COHORT OF MEN WITH FAVORABLE-RISK PROSTATE CANCERS
    Tosoian, Jeffrey
    Morais, Carlos
    Guedes, Liana
    Meliti, Abdelrazak
    Glavaris, Stephanie
    Alam, Ridwan
    Chappidi, Meera
    Mullane, Patrick
    Schaeffer, Edward
    Carter, H. Ballentine
    DeMarzo, Angelo
    Ross, Ashley
    Lotan, Tamara
    JOURNAL OF UROLOGY, 2016, 195 (04): : E82 - E83
  • [47] DISCUSSION ON EXPECTANT MANAGEMENT OF PROSTATE-CANCER
    EVANS, RA
    JOURNAL OF UROLOGY, 1995, 153 (06): : 1954 - 1955
  • [48] Expectant management: an option for localized prostate cancer
    M A Khan
    A W Partin
    Prostate Cancer and Prostatic Diseases, 2005, 8 : 311 - 315
  • [49] Expectant management of prostate cancer with curative intent
    Carter, HB
    Landis, PK
    Epstein, JI
    Walsh, PC
    EUROPEAN UROLOGY, 2001, 39 : 24 - 24
  • [50] OUTCOMES OF RADIATION FOLLOWING EXPECTANT MANAGEMENT FOR LOW RISK, LOCALIZED PROSTATE CANCER
    Komisarenko, Maria
    Ahmad, Ardalan E.
    Chua, Melvin
    Murgic, Jure
    Finelli, Antonio
    JOURNAL OF UROLOGY, 2016, 195 (04): : E144 - E144
12345